As shown in Figure 3a, the highest frequency of HSP90B1 alterations (>6 percent) was observed in patients with UCEC who had a “mutation” as the primary feature, followed by patients with BLCA. Here, HSP90B1 is linked to bladder transitional cell carcinoma.